mutation predictions | marginal predictions | summary statistics | genome diff | command line log
|
breseq version 0.33.1 revision 8505477f25b3
mutation predictions | marginal predictions | summary statistics | genome diff | command line log |
| Predicted mutations | |||||
|---|---|---|---|---|---|
| evidence | position | mutation | annotation | gene | description |
| RA | 547,694 | A→G | intergenic (+123/‑1156) | fdrA → / → ylbF | acyl‑CoA synthetase with NAD(P)‑bindingRossmann‑fold domain/hypothetical protein |
| RA | 547,835 | +G | intergenic (+264/‑1015) | fdrA → / → ylbF | acyl‑CoA synthetase with NAD(P)‑bindingRossmann‑fold domain/hypothetical protein |
| RA | 556,858 | A→T | L36Q (CTG→CAG) | folD ← | bifunctional 5,10‑methylene‑tetrahydrofolatedehydrogenase/5,10‑methylene ‑tetrahydrofolatecyclohydrolase |
| MC JC | 654,214 | Δ1,199 bp | insH_12 | insH_12 | |
| RA | 967,490 | G→T | G150C (GGT→TGT) | msbA → | lipid ABC transporter ATP‑bindingprotein/membrane protein |
| RA | 987,574 | G→T | intergenic (‑170/+433) | ompF ← / ← asnS | outer membrane porin 1a (Ia;b;F)/asparaginyl tRNA synthetase |
| RA | 1,093,686 | T→C | V130A (GTA→GCA) | ycdT → | diguanylate cyclase |
| RA | 1,197,797 | C→T | H366H (CAC→CAT) | icd → | isocitrate dehydrogenase,‑specific for NADP+ |
| RA | 1,197,809 | C→T | T370T (ACC→ACT) | icd → | isocitrate dehydrogenase,‑specific for NADP+ |
| RA | 1,197,822 | T→C | L375M (TTA→CTG) | icd → | isocitrate dehydrogenase,‑specific for NADP+ |
| RA | 1,197,824 | A→G | L375M (TTA→CTG) | icd → | isocitrate dehydrogenase,‑specific for NADP+ |
| MC JC | 1,301,041 | Δ1,336 bp | insC_8–insD_10 | insC_8, insD_10 | |
| RA | 1,519,222 | G→T | V40V (GTG→GTT) | ydcX → | inner membrane protein |
| RA | 1,669,601 | Δ1 bp | coding (678/1221 nt) | dgsA ← | DNA‑binding transcriptional repressor |
| RA | 1,979,957 | G→T | intergenic (‑37/+398) | flhD ← / ← insH_10 | DNA‑binding transcriptional dual regulator/IS5 element protein |
| RA | 2,005,401 | C→T | E115K (GAA→AAA) | fliC ← | flagellar filament structural protein |
| MC JC | 2,176,983 | Δ1,199 bp | insH_11 | insH_11 | |
| RA | 2,245,455 | A→G | S283P (TCG→CCG) | yeiB ← | inner membrane protein |
| MC JC | 2,320,795 | Δ1,336 bp | insD_9–insC_5 | insD_9, insC_5 | |
| RA | 2,866,111 | A→G | intergenic (‑21/+159) | rpoS ← / ← nlpD | RNA polymerase, sigma S (sigma 38) factor/outer membrane lipoprotein |
| RA | 3,212,521 | G→A | M273I (ATG→ATA) | rpoD → | RNA polymerase, sigma 70 (sigma D) factor |
| MC JC | 3,261,134 | Δ1,199 bp | insH_16–[tdcD] | insH_16, [tdcD] | |
| RA | 3,268,825 | A→G | T186A (ACA→GCA) | yhaC → | hypothetical protein |
| RA | 3,693,457 | +A | noncoding (1417/1542 nt) | rrsC ← | 16S ribosomal RNA |
| MC JC | 3,742,936 | Δ1,336 bp | insD_8–insC | insD_8, insC | |
| MC JC | 3,746,911 | Δ1,199 bp | insH_13 | insH_13 | |
| MC JC | 3,958,123 | Δ34 bp | coding (1156‑1189/1287 nt) | dctA → | C4‑dicarboxylic acid, orotate and citratetransporter |
| MC JC | 4,310,363 | Δ1,199 bp | insH_15–[alsK] | insH_15, [alsK] | |
| RA | 4,371,274 | (A)5→3 | intergenic (‑9/+296) | dcuA ← / ← aspA | C4‑dicarboxylate antiporter/aspartate ammonia‑lyase |
| Unassigned missing coverage evidence | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| seq id | start | end | size | ←reads | reads→ | gene | description | |||
| * | * | ÷ | NC_007779_cfb | 1197849 | 1213073 | 15225 | 56 [51] | [50] 53 | [icd]–mcrA | [icd],ymfD,ymfE,lit,intE,xisE,ymfH,ymfI,ymfJ,cohE,croE,ymfL,ymfM,ymfN,ymfR,ymfO,ymfP,ymfQ,stfP,tfaP,tfaE,pinE,mcrA |
| * | * | ÷ | NC_007779_cfb | 1394444 | 1398802–1397759 | 3316–4359 | 155 [0] | [51] 53 | [ycjZ]–[insH_8] | [ycjZ],mppA,ynaI,[insH_8] |
| * | * | ÷ | NC_007779_cfb | 3972854 | 3988219–3987180 | 14327–15366 | 128 [2] | [51] 53 | [gadA]–[insH] | [gadA],gadX,gadW,mdtF,mdtE,gadE,hdeD,hdeA,hdeB,yhiD,dctR,slp,[insH] |
| Unassigned new junction evidence | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| seq id | position | reads (cov) | reads (cov) | score | skew | freq | annotation | gene | product | ||
| * | ? | NC_007779_cfb | 380484 = | NA (NA) | 129 (1.070) | 111/434 | 0.1 | NA | intergenic (‑418/‑46) | yaiO/insC_2 | hypothetical protein/IS2 insertion element repressor InsA |
| ? | NC_007779_cfb | = 381407 | NA (NA) | coding (510/906 nt) | insD | IS2 insertion element transposase InsAB' | |||||
| * | ? | NC_007779_cfb | 381401 = | NA (NA) | 125 (1.040) | 105/430 | 0.2 | NA | coding (504/906 nt) | insD | IS2 insertion element transposase InsAB' |
| ? | NC_007779_cfb | = 381812 | NA (NA) | coding (303/387 nt) | yaiF | hypothetical protein | |||||
| * | ? | NC_007779_cfb | = 1394443 | 0 (0.000) | 146 (1.210) | 118/432 | 0.1 | 100% | coding (739/900 nt) | ycjZ | DNA‑binding transcriptional regulator |
| ? | NC_007779_cfb | 1397759 = | NA (NA) | intergenic (‑123/‑31) | ynaI/insH_8 | inner membrane protein/IS5 transposase and trans‑activator | |||||
| * | ? | NC_007779_cfb | 2519723 = | NA (NA) | 143 (1.200) | 120/428 | 0.1 | 97.3% | intergenic (+33/‑54) | nupC/insL | nucleoside (except guanosine) transporter/transposase |
| ? | NC_007779_cfb | = 4548296 | 4 (0.030) | coding (502/549 nt) | fimA | major type 1 subunit fimbrin | |||||
| * | ? | NC_007779_cfb | = 2521059 | NA (NA) | 150 (1.260) | 125/428 | 0.0 | 96.2% | intergenic (+170/+30) | insL/yfeA | transposase/diguanylate cyclase |
| ? | NC_007779_cfb | 4548285 = | 6 (0.050) | coding (491/549 nt) | fimA | major type 1 subunit fimbrin | |||||
| * | ? | NC_007779_cfb | = 3186081 | NA (NA) | 115 (0.960) | 94/432 | 0.4 | 98.3% | coding (26/2466 nt) | yqiG | outer membrane usher protein |
| ? | NC_007779_cfb | 3512753 = | 2 (0.020) | coding (529/1026 nt) | cytR | DNA‑binding transcriptional dual regulator | |||||
| * | ? | NC_007779_cfb | = 3512759 | 1 (0.010) | 99 (0.820) | 86/432 | 0.6 | 99.0% | coding (535/1026 nt) | cytR | DNA‑binding transcriptional dual regulator |
| ? | NC_007779_cfb | = 3744262 | NA (NA) | intergenic (‑90/+31) | insC/yidZ | IS2 element protein/DNA‑binding transcriptional regulator | |||||
| * | ? | NC_007779_cfb | 3670529 = | 5 (0.040) | 164 (1.360) | 110/434 | 0.1 | 97.0% | intergenic (‑79/+62) | rhoL/trxA | rho operon leader peptide/thioredoxin 1 |
| ? | NC_007779_cfb | 3746911 = | NA (NA) | intergenic (‑509/‑68) | mdtL/insH_13 | multidrug efflux system protein/IS5 element protein | |||||
| * | ? | NC_007779_cfb | = 3670532 | 0 (0.000) | 133 (1.100) | 101/434 | 0.3 | 100% | intergenic (‑82/+59) | rhoL/trxA | rho operon leader peptide/thioredoxin 1 |
| ? | NC_007779_cfb | = 3748105 | NA (NA) | intergenic (+146/+966) | insH_13/tnaA | IS5 element protein/tryptophanase/L‑cysteine desulfhydrase,PLP‑dependent | |||||
| * | ? | NC_007779_cfb | = 3744263 | NA (NA) | 145 (1.200) | 113/434 | 0.1 | 98.6% | intergenic (‑91/+30) | insC/yidZ | IS2 element protein/DNA‑binding transcriptional regulator |
| ? | NC_007779_cfb | 3903274 = | 2 (0.020) | coding (37/825 nt) | bax | hypothetical protein | |||||
| * | ? | NC_007779_cfb | 3746911 = | NA (NA) | 125 (1.030) | 102/434 | 0.3 | 98.4% | intergenic (‑509/‑68) | mdtL/insH_13 | multidrug efflux system protein/IS5 element protein |
| ? | NC_007779_cfb | = 3972853 | 2 (0.020) | coding (19/1401 nt) | gadA | glutamate decarboxylase A, PLP‑dependent | |||||
| * | ? | NC_007779_cfb | = 3750590 | 0 (0.000) | 129 (1.090) | 106/426 | 0.2 | 100% | intergenic (‑104/‑69) | tnaA/insH_14 | tryptophanase/L‑cysteine desulfhydrase,PLP‑dependent/IS5 element protein |
| ? | NC_007779_cfb | 3751790 = | 0 (0.000) | intergenic (+151/+116) | insH_14/tnaC | IS5 element protein/tryptophanase leader peptide | |||||
| * | ? | NC_007779_cfb | = 3903279 | 1 (0.010) | 151 (1.250) | 119/432 | 0.1 | 99.4% | coding (42/825 nt) | bax | hypothetical protein |
| ? | NC_007779_cfb | = 4504190 | NA (NA) | intergenic (+10/‑89) | insD_3/yjgW | IS2 insertion element transposase InsAB'/hypothetical protein | |||||
| * | ? | NC_007779_cfb | 4056220 = | NA (NA) | 142 (1.170) | 118/434 | 0.1 | 95.3% | intergenic (‑209/+15) | yrhD/insB | Gene added/IS1 transposase InsAB' |
| ? | NC_007779_cfb | 4357350 = | 7 (0.060) | coding (89/297 nt) | yjdK | hypothetical protein | |||||
| * | ? | NC_007779_cfb | 4056220 = | NA (NA) | 133 (1.100) | 117/434 | 0.1 | 95.7% | intergenic (‑209/+15) | yrhD/insB | Gene added/IS1 transposase InsAB' |
| ? | NC_007779_cfb | = 4365911 | 6 (0.050) | coding (702/1539 nt) | cadC | DNA‑binding transcriptional activator | |||||
| * | ? | NC_007779_cfb | = 4056987 | NA (NA) | 148 (1.220) | 128/434 | 0.0 | 100% | coding (388/414 nt) | yrhA | hypothetical protein |
| ? | NC_007779_cfb | = 4357358 | 0 (0.000) | coding (97/297 nt) | yjdK | hypothetical protein | |||||
| * | ? | NC_007779_cfb | = 4056987 | NA (NA) | 144 (1.190) | 117/434 | 0.1 | 97.3% | coding (388/414 nt) | yrhA | hypothetical protein |
| ? | NC_007779_cfb | 4365903 = | 4 (0.030) | coding (710/1539 nt) | cadC | DNA‑binding transcriptional activator | |||||
| * | ? | NC_007779_cfb | = 4311556 | NA (NA) | 114 (0.950) | 99/432 | 0.3 | 99.1% | coding (922/1029 nt) | alsK | D‑allose kinase |
| ? | NC_007779_cfb | 4540915 = | 1 (0.010) | intergenic (+204/+379) | yjhR/nanS | frameshift suppressor/hypothetical protein | |||||